Data integrity is the extent to which all data are complete, consistent, and accurate throughout the data lifecycle. In pharmaceutical manufacturing, data integrity is a regulatory requirement that ensures product quality, patient safety, and the reliability of submitted information. The MHRA and FDA define data integrity as the degree to which data attributes are maintained and assured.

What Is Data Integrity?

Data integrity encompasses the completeness, consistency, and accuracy of data from initial creation through archival or disposal. It applies to both raw data and metadata, including audit trails and any data generated during testing, manufacturing, or distribution. A data integrity failure can lead to product recalls, regulatory sanctions, and harm to public health.

Principles

The core principles of data integrity are captured by the ALCOA+ framework, which defines the attributes that data must possess to be considered reliable. Data must be attributable to the person who generated it, legible and permanently recorded, contemporaneous with the activity, original or a true copy, and accurate. The extended ALCOA+ attributes of complete, consistent, enduring, and available address modern electronic system challenges.

Best Practices

Protect data integrity by implementing access controls, validation of computerized systems, and secure audit trail functionality. Establish and enforce Good Documentation Practices for all manual data entry, and conduct regular data integrity audits. Ensure that personnel at all levels understand their role in maintaining data integrity through comprehensive training programs.

Regulatory Requirements

Data integrity is enforced under 21 CFR Part 11, EU Annex 11, and ICH Q7 through Q10. The FDA’s 2018 Data Integrity and Compliance With CGMP guidance emphasizes that data must meet ALCOA+ standards and that electronic records are equivalent to paper records when properly controlled. Regulatory agencies increasingly focus on data governance systems during inspections.

Conclusion

Data integrity is not merely a compliance issue but a fundamental requirement for producing safe and effective pharmaceutical products. A robust data integrity program reduces risk, improves operational efficiency, and builds regulatory trust. Every organization should prioritize data integrity as a core element of its quality management system.